Bhanderi, M.; Shah, J.; Gorain, B.; Nair, A.B.; Jacob, S.; Asdaq, S.M.B.; Fattepur, S.; Alamri, A.S.; Alsanie, W.F.; Alhomrani, M.;
et al. Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies. Materials 2021, 14, 6291.
https://doi.org/10.3390/ma14216291
AMA Style
Bhanderi M, Shah J, Gorain B, Nair AB, Jacob S, Asdaq SMB, Fattepur S, Alamri AS, Alsanie WF, Alhomrani M,
et al. Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies. Materials. 2021; 14(21):6291.
https://doi.org/10.3390/ma14216291
Chicago/Turabian Style
Bhanderi, Mansi, Jigar Shah, Bapi Gorain, Anroop B. Nair, Shery Jacob, Syed Mohammed Basheeruddin Asdaq, Santosh Fattepur, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani,
and et al. 2021. "Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies" Materials 14, no. 21: 6291.
https://doi.org/10.3390/ma14216291
APA Style
Bhanderi, M., Shah, J., Gorain, B., Nair, A. B., Jacob, S., Asdaq, S. M. B., Fattepur, S., Alamri, A. S., Alsanie, W. F., Alhomrani, M., Nagaraja, S., & Anwer, M. K.
(2021). Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies. Materials, 14(21), 6291.
https://doi.org/10.3390/ma14216291